Last Updated: September 24, 2026

CESAMET Drug Patent Profile

Name: CESAMET Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Cesamet, and what generic alternatives are available?

Cesamet is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in CESAMET is nabilone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nabilone profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CESAMET?
What are the global sales for CESAMET?
What is Average Wholesale Price for CESAMET?

Summary for CESAMET

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	21
Clinical Trials:	17
Patent Applications:	5,541
Drug Prices:	Drug price information for CESAMET
What excipients (inactive ingredients) are in CESAMET?	CESAMET excipients list
DailyMed Link:	CESAMET at DailyMed

Drug patent expirations by year for CESAMET

Recent Clinical Trials for CESAMET

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Samuel Lunenfeld Research Institute, Mount Sinai Hospital	N/A
New York State Psychiatric Institute	Phase 2
National Institute of Mental Health (NIMH)	Phase 1/Phase 2

See all CESAMET clinical trials

Pharmacology for CESAMET

Drug Class	Cannabinoid

US Patents and Regulatory Information for CESAMET

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CESAMET

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	3,920,809	⤷ Start Trial
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	4,087,547	⤷ Start Trial
Bausch	CESAMET	nabilone	CAPSULE;ORAL	018677-001	Dec 26, 1985	4,087,545	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CESAMET

See the table below for patents covering CESAMET around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Australia	7343074		⤷ Start Trial
Belgium	821718		⤷ Start Trial
Canada	1023270	BIBENZO (B,D) PYRANONE DISPERSIONS	⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.